New York State Common Retirement Fund Protalix Bio Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$1.1 - $1.32 $49,610 - $59,532	-45,100 Reduced 98.78%	555 $1,000
Q1 2024 May 07, 2024	BUY	$1.22 - $1.82 $677 - $1,010	555 Added 1.23%	45,655 $58,000
Q4 2023 Feb 01, 2024	SELL	$1.34 - $1.85 $938 - $1,295	-700 Reduced 1.53%	45,100 $80,000
Q3 2023 Nov 07, 2023	BUY	$1.49 - $2.02 $1,043 - $1,414	700 Added 1.55%	45,800 $76,000
Q2 2023 Aug 07, 2023	BUY	$2.0 - $3.36 $90,200 - $151,536	45,100 New	45,100 $90,000

3.6M

61.1K

36.2K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $111M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.